James D Murphy
Overview
Explore the profile of James D Murphy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
214
Citations
4571
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Qiao E, Guram K, Kotha N, Voora R, Qian A, Ahn G, et al.
JAMA Netw Open
. 2022 Nov;
5(11):e2242048.
PMID: 36374497
Importance: Primary care physicians (PCPs) are significant contributors of early cancer detection, yet few studies have investigated whether consistent primary care translates to improved downstream outcomes. Objective: To evaluate the...
22.
Riviere P, Kalavacherla S, Banegas M, Javier-Desloges J, Martinez M, Garraway I, et al.
Cancer
. 2022 Nov;
129(1):82-88.
PMID: 36345568
Background: The 2018 US Preventive Services Task Force guidelines recommend individualizing prostate cancer screening in 55- to 69-year-old men. Given the higher incidence of prostate cancer in African American (AA)...
23.
Atwood T, Brown D, Murphy J, Moore K, Juang T, Azuara A, et al.
Int J Radiat Oncol Biol Phys
. 2022 Oct;
115(1):224-232.
PMID: 36289039
Purpose: Our purpose was to investigate the effect of physicist-patient consults on patient anxiety and patient satisfaction with a randomized prospective phase III clinical trial. Methods And Materials: Sixty-six patients...
24.
Bryant A, Lee K, Alba P, Murphy J, Martinez M, Natarajan L, et al.
JAMA Oncol
. 2022 Oct;
8(12):1747-1755.
PMID: 36279204
Importance: There is controversy about the benefit of prostate-specific antigen (PSA) screening. Prostate-specific antigen screening rates have decreased since 2008 in the US, and the incidence of metastatic prostate cancer...
25.
Obrochta C, Parada Jr H, Murphy J, Nara A, Trinidad D, Happy Araneta M, et al.
PLoS One
. 2022 Oct;
17(10):e0272076.
PMID: 36197902
Background: Travel time to treatment facilities may impede the receipt of guideline-concordant treatment (GCT) among patients diagnosed with early-stage non-small cell lung cancer (ES-NSCLC). We investigated the relative contribution of...
26.
Banegas M, Dickerson J, Zheng Z, Murphy C, Tucker-Seeley R, Murphy J, et al.
JAMA Netw Open
. 2022 Sep;
5(9):e2233009.
PMID: 36112380
No abstract available.
27.
Martinez M, Gomez S, Canchola A, Oh D, Murphy J, Mehtsun W, et al.
Front Oncol
. 2022 Aug;
12:916167.
PMID: 35912225
Although Affordable Care Act (ACA) implementation has improved cancer outcomes, less is known about how much the improvement applies to different racial and ethnic populations. We examined changes in health...
28.
Qiao E, Qian A, Nalawade V, Voora R, Kotha N, Vitzthum L, et al.
JCO Clin Cancer Inform
. 2022 Jun;
6:e2100186.
PMID: 35671416
Purpose: Older hospitalized cancer patients face high risks of hospital mortality. Improved risk stratification could help identify high-risk patients who may benefit from future interventions, although we lack validated tools...
29.
Bryant A, Nelson T, McKay R, Kader A, Parsons J, Einck J, et al.
BJUI Compass
. 2022 May;
3(3):243-250.
PMID: 35492227
Objective: To analyse the effect of age at diagnosis on clinical outcomes of localized prostate cancer (PCa) treated with radiation therapy. Subjects And Methods: We identified 12 784 patients with...
30.
Javier-Desloges J, Nelson T, Murphy J, McKay R, Stewart T, Kader A, et al.
Urol Oncol
. 2022 Apr;
40(5):199.e15-199.e21.
PMID: 35431133
Objectives: To determine the representation of women, minorities, and the elderly groups in clinical trials and whether participation has changed over time. Methods: Retrospective study in the National Cancer Institute...